RLAY
Relay Therapeutics·NASDAQ
--
--(--)
--
--(--)
RLAY fundamentals
Relay Therapeutics (RLAY) released its earnings on Feb 26, 2026: revenue was 7.00M (YoY --), beat estimates; EPS was -0.32 (YoY +28.89%), beat estimates.
Revenue / YoY
7.00M
--
EPS / YoY
-0.32
+28.89%
Report date
Feb 26, 2026
EPS
Actual | -6.06 | 0.36 | -0.47 | -2.1 | -0.66 | -0.59 | -0.57 | -0.71 | -0.76 | -0.56 | -0.78 | -0.81 | -0.54 | -0.67 | -0.62 | -0.69 | -0.63 | -0.45 | -0.46 | -0.41 | -0.43 | -0.32 |
Forecast | -0.3767 | 0.1683 | -0.4857 | -0.4486 | -0.612 | -0.5589 | -0.6183 | -0.6271 | -0.7056 | -0.7022 | -0.6912 | -0.8155 | -0.825 | -0.7182 | -0.7268 | -0.7327 | -0.7719 | -0.5612 | -0.4893 | -0.4918 | -0.4153 | -0.4046 |
Surprise | -1508.71% | +113.90% | +3.23% | -368.12% | -7.84% | -5.56% | +7.81% | -13.22% | -7.71% | +20.25% | -12.85% | +0.67% | +34.55% | +6.71% | +14.69% | +5.83% | +18.38% | +19.81% | +5.99% | +16.63% | -3.54% | +20.91% |
Revenue
Actual | 0 | 82.65M | 952.00K | 844.00K | 666.00K | 567.00K | 419.00K | 365.00K | 344.00K | 253.00K | 226.00K | 119.00K | 25.20M | -4.00K | 10.00M | 0 | 0 | 0 | 7.68M | 700.00K | 0 | 7.00M |
Forecast | 0 | 36.67M | 3.39M | 6.67M | 107.14K | 3.84M | 166.67K | 2.08M | 1.80M | 271.43K | 128.00K | 741.67K | 374.55K | 581.82K | 120.00K | 88.89K | 88.89K | 6.08M | 14.29K | 75.00K | 160.00K | 4.97M |
Surprise | 0.00% | +125.42% | -71.93% | -87.34% | +521.60% | -85.23% | +151.40% | -82.48% | -80.89% | -6.79% | +76.56% | -83.96% | +6628.70% | -100.69% | +8233.33% | -100.00% | -100.00% | -100.00% | +53651.93% | +833.33% | -100.00% | +40.96% |
Earnings Call
You can ask Aime
What were the key takeaways from Relay Therapeutics’s earnings call?What is Relay Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Relay Therapeutics's revenue and profit?What is Relay Therapeutics's gross profit margin?Did Relay Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Relay Therapeutics next quarter?What guidance did Relay Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Relay Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
